Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 14, 2020 05:50PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
RVXOT, we're left with a conundrum seeing that "ZHCLF" is trading on the OTC according to josh4580.
So if it's not ZCC (Calgary, & I agree with that notion because Zenith, Calgary said so), who could it be. Does it mean that FIRNA assigned "ZHCLF" to another company trading on the OTC - and it so happens that it has the same number of outstanding shares as ZCC, Calgary?
EOM ... Koo